Paris: Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. This acquisition strengthens Sanofi's ...

Sanofi completes the acquisition of Vigil Neuroscience, Inc.Paris, August 6, 2025. Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. ('Vigil”). This acquisition ...

Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

The health department ends 22 federal investments as data showed they fail to protect against Covid and flu infections effectively.

Building on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...

The U.S. Department of Health and Human Services announced on August 5, 2025, that the coordinated programs of mRNA vaccine development under the Biomedical Advanced Research and ...

It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.

AI research is central to many of the deals. In April, French pharmaceutical giant Sanofi announced a $1.7 billion agreement ...

The United States Department of Health and Human Services said yesterday it would wind down mRNA vaccine development activities under its biomedical research unit.

Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business ...

Procurement Magazine takes a look at the Top 10 companies leading the charge when it comes to trailblazing supplier diversity ...